000180472 001__ 180472
000180472 005__ 20240229145619.0
000180472 0247_ $$2doi$$a10.3390/cancers14123010
000180472 0247_ $$2pmid$$apmid:35740675
000180472 0247_ $$2altmetric$$aaltmetric:130284621
000180472 037__ $$aDKFZ-2022-01351
000180472 041__ $$aEnglish
000180472 082__ $$a610
000180472 1001_ $$aForster, Tobias$$b0
000180472 245__ $$aMethods of Esthetic Assessment after Adjuvant Whole-Breast Radiotherapy in Breast Cancer Patients: Evaluation of the BCCT.core Software and Patients' and Physicians' Assessment from the Randomized IMRT-MC2 Trial.
000180472 260__ $$aBasel$$bMDPI$$c2022
000180472 3367_ $$2DRIVER$$aarticle
000180472 3367_ $$2DataCite$$aOutput Types/Journal article
000180472 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1656334372_4495
000180472 3367_ $$2BibTeX$$aARTICLE
000180472 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000180472 3367_ $$00$$2EndNote$$aJournal Article
000180472 500__ $$a#LA:E050#
000180472 520__ $$aThe present analysis compares the esthetics assessment by the BCCT.core software in relation to patients' and physicians' ratings, based on the IMRT-MC2 trial. Within this trial, breast cancer patients received breast-conserving surgery (BCS) and adjuvant radiotherapy. At the baseline, 6 weeks, and 2 years after radiotherapy, photos of the breasts were assessed by the software and patients' and physicians' assessments were performed. Agreement rates of the assessments and their correlation with breast asymmetry indices were evaluated. The assessments of the software and the physicians were significantly correlated with asymmetry indices. Before and 6 weeks after radiotherapy, the patients' self-assessment was only correlated with the lower breast contour (LBC) and upward nipple retraction (UNR), while after 2 years, there was also a correlation with other indices. Only a slight agreement between the BCCT.core software and the physicians' or patients' assessment was seen, while a moderate and substantial agreement was detected between the physicians' and the patients' assessment after 6 weeks and 2 years, respectively. The BCCT.core software is a reliable tool to measure asymmetries, but may not sufficiently evaluate the esthetic outcome as perceived by patients. It may be more appropriate for a long-term follow-up, when symmetry appears to increase in importance.
000180472 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000180472 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000180472 650_7 $$2Other$$aBCCT.core software
000180472 650_7 $$2Other$$aadjuvant whole-breast radiotherapy
000180472 650_7 $$2Other$$abreast cancer
000180472 650_7 $$2Other$$acosmesis
000180472 650_7 $$2Other$$aesthetic assessment
000180472 7001_ $$aKöhler, Clara$$b1
000180472 7001_ $$aDorn, Melissa$$b2
000180472 7001_ $$aHäfner, Matthias Felix$$b3
000180472 7001_ $$00000-0002-2389-5404$$aArians, Nathalie$$b4
000180472 7001_ $$aKönig, Laila$$b5
000180472 7001_ $$00000-0003-1195-7150$$aHarrabi, Semi Ben$$b6
000180472 7001_ $$aSchlampp, Ingmar$$b7
000180472 7001_ $$00000-0001-7087-9581$$aMeixner, Eva$$b8
000180472 7001_ $$aHeinrich, Vanessa$$b9
000180472 7001_ $$aWeidner, Nicola$$b10
000180472 7001_ $$00000-0002-2605-0060$$aGolatta, Michael$$b11
000180472 7001_ $$aHennigs, André$$b12
000180472 7001_ $$aHeil, Jörg$$b13
000180472 7001_ $$aHof, Holger$$b14
000180472 7001_ $$aKrug, David$$b15
000180472 7001_ $$0P:(DE-He78)8714da4e45acfa36ce87c291443a9218$$aDebus, Jürgen$$b16$$udkfz
000180472 7001_ $$0P:(DE-He78)c59ff25b48c192ed3fd4ad3a4bc9b9c0$$aHörner-Rieber, Juliane$$b17$$eLast author$$udkfz
000180472 773__ $$0PERI:(DE-600)2527080-1$$a10.3390/cancers14123010$$gVol. 14, no. 12, p. 3010 -$$n12$$p3010$$tCancers$$v14$$x2072-6694$$y2022
000180472 909CO $$ooai:inrepo02.dkfz.de:180472$$pVDB
000180472 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8714da4e45acfa36ce87c291443a9218$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000180472 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c59ff25b48c192ed3fd4ad3a4bc9b9c0$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000180472 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000180472 9141_ $$y2022
000180472 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-05-04
000180472 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-05-04
000180472 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-05-04
000180472 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-05-04
000180472 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-05-04
000180472 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-05-04
000180472 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCERS : 2021$$d2022-11-30
000180472 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-30
000180472 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-30
000180472 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2022-01-24T07:56:58Z
000180472 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2022-01-24T07:56:58Z
000180472 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2022-01-24T07:56:58Z
000180472 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-30
000180472 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-30
000180472 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-30
000180472 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-30
000180472 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-30
000180472 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCERS : 2021$$d2022-11-30
000180472 9202_ $$0I:(DE-He78)E050-20160331$$kE050$$lE050 KKE Strahlentherapie$$x0
000180472 9201_ $$0I:(DE-He78)E050-20160331$$kE050$$lE050 KKE Strahlentherapie$$x0
000180472 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000180472 980__ $$ajournal
000180472 980__ $$aVDB
000180472 980__ $$aI:(DE-He78)E050-20160331
000180472 980__ $$aI:(DE-He78)HD01-20160331
000180472 980__ $$aUNRESTRICTED